Shapiro David

Director at NESS TECHNOLOGIES INC · on record since May 18, 2023
Director at DYNAMIC LEISURE CORP · on record since Jan 18, 2007
Director at Design Therapeutics, Inc. · on record since Apr 1, 2026
Director at GLOBAL BRASS & COPPER HOLDINGS, INC. · on record since May 30, 2013
Director at Bulova Technologies Group, Inc. · on record since Nov 24, 2014
Chief Operating Officer at Propel Media, Inc. · on record since May 8, 2017
Chief Medical Officer at INTERCEPT PHARMACEUTICALS, INC. · on record since Feb 22, 2018
Director at ORGANOVO HOLDINGS, INC. · on record since Dec 6, 2018
Director at Damora Therapeutics, Inc. · on record since Oct 28, 2020
Director at Northern Star Investment Corp. II · on record since Jan 25, 2021

Insider trading activity of Shapiro David

Transactions on record: 351; since Oct 24, 2007

Open-market buys: 2; $37.4K

Open-market sells: 174; $246.3M

Companies traded: 8; last filing Jun 11, 2026

Figures computed from official regulatory filings — .

Companies where Shapiro David has traded

Design Therapeutics, Inc.3 tx · Jun 11, 2026
Damora Therapeutics, Inc.4 tx · Jun 20, 2025
ORGANOVO HOLDINGS, INC.3 tx · Sep 9, 2019
INTERCEPT PHARMACEUTICALS, INC.333 tx · $39.9M · May 3, 2019
Propel Media, Inc.2 tx · $17.4K · May 8, 2017
Bulova Technologies Group, Inc.1 tx · $20K · Nov 24, 2014
3 tx · $209.2M · Feb 5, 2014
2 tx · $34K · Apr 7, 2008

Track record of Shapiro David

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Shapiro David

Co-insiders of Shapiro David

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Design Therapeutics, Inc.	Jun 11, 2026	AwardD (derivative)	30,000	0.00 USD	—	SEC
Design Therapeutics, Inc.	Apr 1, 2026	AwardD (derivative)	7,500	0.00 USD	—	SEC
Design Therapeutics, Inc.	Apr 1, 2026	AwardD (derivative)	60,000	0.00 USD	—	SEC
Damora Therapeutics, Inc.	Jun 20, 2025	AwardD (derivative)	720	0.00 USD	—	SEC
Damora Therapeutics, Inc.	Jun 21, 2024	AwardD (derivative)	18,000	0.00 USD	—	SEC
Damora Therapeutics, Inc.	Jun 15, 2023	AwardD (derivative)	18,000	0.00 USD	—	SEC
Damora Therapeutics, Inc.	Jun 15, 2022	AwardD (derivative)	18,000	0.00 USD	—	SEC
ORGANOVO HOLDINGS, INC.	Sep 9, 2019	AwardD (derivative)	52,000	0.00 USD	—	SEC
INTERCEPT PHARMACEUTICALS, INC.	May 3, 2019	Exercise	2,000	31.90 USD	$63.8K	SEC
INTERCEPT PHARMACEUTICALS, INC.	May 3, 2019	ExerciseD (derivative)	-2,000	0.00 USD	—	SEC
INTERCEPT PHARMACEUTICALS, INC.	May 3, 2019	Sell	-2,000	86.28 USD	$172.6K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Apr 16, 2019	ExerciseD (derivative)	-2,000	0.00 USD	—	SEC
INTERCEPT PHARMACEUTICALS, INC.	Apr 16, 2019	Exercise	2,000	31.90 USD	$63.8K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Apr 16, 2019	Sell	-2,000	95.00 USD	$190K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Apr 3, 2019	Other	-482	111.50 USD	$53.7K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Apr 3, 2019	Sell	-562	115.01 USD	$64.6K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Mar 1, 2019	ExerciseD (derivative)	-2,000	0.00 USD	—	SEC
INTERCEPT PHARMACEUTICALS, INC.	Mar 1, 2019	Exercise	2,000	31.90 USD	$63.8K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Mar 1, 2019	Sell	-2,000	103.16 USD	$206.3K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Feb 20, 2019	Exercise	2,000	31.90 USD	$63.8K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Feb 20, 2019	ExerciseD (derivative)	-2,000	0.00 USD	—	SEC
INTERCEPT PHARMACEUTICALS, INC.	Feb 20, 2019	Sell	-2,000	111.51 USD	$223K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Jan 18, 2019	AwardD (derivative)	5,300	0.00 USD	—	SEC
INTERCEPT PHARMACEUTICALS, INC.	Jan 18, 2019	Award	3,300	0.00 USD	—	SEC
INTERCEPT PHARMACEUTICALS, INC.	Jan 4, 2019	Sell	-474	97.48 USD	$46.2K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Design Therapeutics, Inc.	Jun 11, 2026	AwardD (derivative)	30,000	0.00 USD	—	SEC
Design Therapeutics, Inc.	Apr 1, 2026	AwardD (derivative)	7,500	0.00 USD	—	SEC
Design Therapeutics, Inc.	Apr 1, 2026	AwardD (derivative)	60,000	0.00 USD	—	SEC
Damora Therapeutics, Inc.	Jun 20, 2025	AwardD (derivative)	720	0.00 USD	—	SEC
Damora Therapeutics, Inc.	Jun 21, 2024	AwardD (derivative)	18,000	0.00 USD	—	SEC
Damora Therapeutics, Inc.	Jun 15, 2023	AwardD (derivative)	18,000	0.00 USD	—	SEC
Damora Therapeutics, Inc.	Jun 15, 2022	AwardD (derivative)	18,000	0.00 USD	—	SEC
ORGANOVO HOLDINGS, INC.	Sep 9, 2019	AwardD (derivative)	52,000	0.00 USD	—	SEC
INTERCEPT PHARMACEUTICALS, INC.	May 3, 2019	Exercise	2,000	31.90 USD	$63.8K	SEC
INTERCEPT PHARMACEUTICALS, INC.	May 3, 2019	ExerciseD (derivative)	-2,000	0.00 USD	—	SEC
INTERCEPT PHARMACEUTICALS, INC.	May 3, 2019	Sell	-2,000	86.28 USD	$172.6K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Apr 16, 2019	ExerciseD (derivative)	-2,000	0.00 USD	—	SEC
INTERCEPT PHARMACEUTICALS, INC.	Apr 16, 2019	Exercise	2,000	31.90 USD	$63.8K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Apr 16, 2019	Sell	-2,000	95.00 USD	$190K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Apr 3, 2019	Other	-482	111.50 USD	$53.7K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Apr 3, 2019	Sell	-562	115.01 USD	$64.6K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Mar 1, 2019	ExerciseD (derivative)	-2,000	0.00 USD	—	SEC
INTERCEPT PHARMACEUTICALS, INC.	Mar 1, 2019	Exercise	2,000	31.90 USD	$63.8K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Mar 1, 2019	Sell	-2,000	103.16 USD	$206.3K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Feb 20, 2019	Exercise	2,000	31.90 USD	$63.8K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Feb 20, 2019	ExerciseD (derivative)	-2,000	0.00 USD	—	SEC
INTERCEPT PHARMACEUTICALS, INC.	Feb 20, 2019	Sell	-2,000	111.51 USD	$223K	SEC
INTERCEPT PHARMACEUTICALS, INC.	Jan 18, 2019	AwardD (derivative)	5,300	0.00 USD	—	SEC
INTERCEPT PHARMACEUTICALS, INC.	Jan 18, 2019	Award	3,300	0.00 USD	—	SEC
INTERCEPT PHARMACEUTICALS, INC.	Jan 4, 2019	Sell	-474	97.48 USD	$46.2K	SEC